Stocks Merck & Co Inc

  • Enthusiasm for the Federal Reserve's actions to stem the credit crunch propelled the Dow Jones Industrial Average to a higher close Monday, a day when everyone expected a rout due to weekend fire sale of Bear Stearns.

  • The Dow Jones Industrial Average pared its losses Monday as the sell-off spurred by the fire sale of Bear Stearns wasn't as bad as expected.

  • Stocks plunged at the opening bell Monday as investors were spooked by the cash crisis at Bear Stearns that forced its sale for $2 a share to JP Morgan Chase.

  • This could be the sector to own by next fall's presidential election.

  • There are too many opportunities for investors to be sitting on the sidelines.

  • The results of the controversial study called "Enhance" of the cholesterol drug Vytorin from Merck and Schering-Plough will not be presented as a prestigious "late breaker" at the upcoming annual meeting of the American College of Cardiology.

  • Splenda

    How much coffee can one woman drink? Watch me. I never drank coffee until I started covering the O.J. Simpson trial (come to think of it, I never drank much alcohol before then, either).

  • graphic_fast_money.jpg

    A top industry insider gives us the dish on a story of the week. Get the details now!

  • february_partial_calendar.jpg

    Taking an extra day off to extend the long weekend before we go into a very busy period. Possibly a week from today (Friday) Genentech could get word from the Food and Drug Administration on its cancer drug Avastin for breast cancer. The agency could approve it, reject it or delay making a decision.

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Stocks rose for their third consecutive gain to complete their longest winning streak of the year so far on strength in oil, tech and other familiar trends. Also, breaking biotech news on Genentech and Biogen in the Word on the Street.

  • And the gains won't last long, Cramer says. Here's how you profit.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • In a CNBC and Mad Money exclusive, Cramer sat down with Schering-Plough CEO Fred Hassan for his first interview since the controversy over the effectiveness of the cholesterol drug Vytorin. Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Stocks closed mixed  Tuesday after an earlier rally inspired by Warren Buffett swooping into the situation with bond insurers and banks teaming up to stop foreclosures.

  • Most of the 30 stocks in the Dow were higher Tuesday after billionaire investor Warren Buffett offered a reinsurance plan to troubled bond insurers and top mortgage lenders unveiled a plan aimed at freezing foreclosures.

  • Most of the 30 stocks in the Dow were higher Tuesday after billionaire investor Warren Buffett offered a reinsurance plan to troubled bond insurers and top mortgage lenders unveiled a plan aimed at freezing foreclosures.

  • vytorin_logo.jpg

    Schering-Plough is bringing up the rear of big pharma earnings season this morning--it reported later than normal because it apparently took longer to do all the accounting for a big acquisition--with a beat on the top and bottom line. But investors, as is usually the case, are more concerned about guidance.

  • Schering-Plough Tuesday reported a quarterly loss as special charges from its acquisition of Organon Biosciences late last year offset sharply higher sales, but results beat Wall Street expectations.

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • The changes announced Monday have Cramer baffled.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.